CordenPharma acted as the seller in this Private Equity transaction.
The divestment involved assets operating in the Pharmaceuticals sector.
The transaction was announced on 04 May 2022 with a reported value of 26000000000.0.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Freshfields advises ICIG as seller and Milbank advises CordenPharma management on Astorg's acquisition of CordenPharma from ICIG. | The Sponsor - The Sponsor
